Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 37 studies | 29% ± 11% | |
fibroblast | 27 studies | 25% ± 9% | |
smooth muscle cell | 22 studies | 23% ± 5% | |
pericyte | 21 studies | 24% ± 8% | |
endothelial cell of lymphatic vessel | 13 studies | 27% ± 8% | |
basal cell | 13 studies | 27% ± 14% | |
ciliated cell | 13 studies | 28% ± 13% | |
astrocyte | 13 studies | 31% ± 12% | |
capillary endothelial cell | 12 studies | 22% ± 6% | |
macrophage | 12 studies | 27% ± 8% | |
endothelial cell of artery | 11 studies | 20% ± 5% | |
vein endothelial cell | 11 studies | 23% ± 9% | |
oligodendrocyte | 11 studies | 27% ± 9% | |
endothelial cell of vascular tree | 10 studies | 26% ± 9% | |
microglial cell | 9 studies | 26% ± 8% | |
adipocyte | 9 studies | 30% ± 9% | |
type I pneumocyte | 8 studies | 22% ± 6% | |
connective tissue cell | 8 studies | 22% ± 4% | |
B cell | 7 studies | 25% ± 6% | |
myofibroblast cell | 7 studies | 21% ± 3% | |
myeloid cell | 7 studies | 26% ± 8% | |
epithelial cell | 7 studies | 42% ± 19% | |
mast cell | 7 studies | 21% ± 7% | |
oligodendrocyte precursor cell | 7 studies | 29% ± 11% | |
natural killer cell | 6 studies | 19% ± 1% | |
classical monocyte | 6 studies | 23% ± 8% | |
abnormal cell | 6 studies | 23% ± 9% | |
club cell | 6 studies | 22% ± 7% | |
Mueller cell | 6 studies | 22% ± 6% | |
type II pneumocyte | 6 studies | 25% ± 9% | |
monocyte | 6 studies | 23% ± 5% | |
non-classical monocyte | 5 studies | 22% ± 6% | |
GABAergic neuron | 5 studies | 36% ± 15% | |
retinal rod cell | 5 studies | 23% ± 8% | |
cardiac muscle cell | 5 studies | 22% ± 3% | |
lymphocyte | 5 studies | 26% ± 5% | |
goblet cell | 5 studies | 29% ± 16% | |
pancreatic A cell | 4 studies | 36% ± 14% | |
naive B cell | 4 studies | 20% ± 4% | |
CD4-positive, alpha-beta T cell | 4 studies | 19% ± 3% | |
retina horizontal cell | 4 studies | 27% ± 7% | |
dendritic cell | 4 studies | 29% ± 9% | |
mesothelial cell | 4 studies | 27% ± 8% | |
secretory cell | 4 studies | 27% ± 16% | |
hepatocyte | 4 studies | 38% ± 20% | |
glutamatergic neuron | 4 studies | 47% ± 14% | |
T cell | 4 studies | 18% ± 2% | |
CD8-positive, alpha-beta memory T cell | 4 studies | 18% ± 2% | |
interneuron | 4 studies | 36% ± 20% | |
pancreatic D cell | 3 studies | 35% ± 20% | |
type B pancreatic cell | 3 studies | 38% ± 14% | |
leukocyte | 3 studies | 24% ± 1% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 2% | |
conventional dendritic cell | 3 studies | 29% ± 12% | |
hematopoietic precursor cell | 3 studies | 27% ± 8% | |
glial cell | 3 studies | 24% ± 7% | |
plasma cell | 3 studies | 29% ± 13% | |
retinal cone cell | 3 studies | 31% ± 10% | |
rod bipolar cell | 3 studies | 22% ± 1% | |
muscle cell | 3 studies | 37% ± 16% | |
ependymal cell | 3 studies | 28% ± 10% | |
enteroendocrine cell | 3 studies | 23% ± 7% | |
intestinal crypt stem cell | 3 studies | 19% ± 1% | |
adventitial cell | 3 studies | 21% ± 2% | |
respiratory goblet cell | 3 studies | 21% ± 6% | |
alveolar macrophage | 3 studies | 30% ± 12% | |
transit amplifying cell | 3 studies | 36% ± 27% | |
neuron | 3 studies | 33% ± 8% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 13 studies | 24% ± 10% | |
brain | 10 studies | 31% ± 14% | |
eye | 8 studies | 25% ± 13% | |
peripheral blood | 4 studies | 28% ± 5% | |
heart | 4 studies | 22% ± 5% | |
liver | 4 studies | 32% ± 12% | |
intestine | 4 studies | 21% ± 8% | |
pancreas | 3 studies | 37% ± 12% | |
uterus | 3 studies | 30% ± 14% | |
adipose | 3 studies | 37% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2621.71 | 1445 / 1445 | 100% | 31.52 | 183 / 183 |
pancreas | 100% | 1299.83 | 328 / 328 | 100% | 22.93 | 178 / 178 |
prostate | 100% | 2483.71 | 245 / 245 | 100% | 24.28 | 502 / 502 |
brain | 100% | 2137.72 | 2641 / 2642 | 100% | 29.73 | 704 / 705 |
lung | 100% | 2528.47 | 577 / 578 | 100% | 23.46 | 1154 / 1155 |
bladder | 100% | 2614.62 | 21 / 21 | 100% | 21.95 | 502 / 504 |
uterus | 100% | 2691.39 | 170 / 170 | 100% | 24.26 | 457 / 459 |
breast | 100% | 2807.62 | 459 / 459 | 100% | 32.89 | 1113 / 1118 |
thymus | 100% | 2806.63 | 653 / 653 | 100% | 28.86 | 602 / 605 |
kidney | 100% | 1880.36 | 89 / 89 | 99% | 21.29 | 889 / 901 |
ovary | 100% | 2273.18 | 180 / 180 | 99% | 14.12 | 424 / 430 |
skin | 100% | 2702.41 | 1809 / 1809 | 99% | 26.43 | 465 / 472 |
stomach | 100% | 1845.54 | 359 / 359 | 98% | 23.66 | 281 / 286 |
intestine | 100% | 2680.83 | 966 / 966 | 98% | 22.09 | 516 / 527 |
adrenal gland | 100% | 1995.14 | 258 / 258 | 97% | 17.23 | 223 / 230 |
liver | 100% | 1143.45 | 226 / 226 | 97% | 12.48 | 393 / 406 |
adipose | 100% | 2898.11 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3650.51 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.20 | 29 / 29 |
muscle | 100% | 1899.08 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2053.22 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 22.23 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.60 | 1 / 1 |
heart | 98% | 1704.52 | 846 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 15.75 | 73 / 80 |
peripheral blood | 67% | 1096.78 | 625 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0001701 | Biological process | in utero embryonic development |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0032502 | Biological process | developmental process |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | NSRP1 |
Protein name | Nuclear speckle splicing regulatory protein 1 Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70) |
Synonyms | CCDC55 hCG_1646942 NSRP70 |
Description | FUNCTION: RNA-binding protein that mediates pre-mRNA alternative splicing regulation. . |
Accessions | ENST00000585881.5 ENST00000479218.6 J3KT62 K7EQJ6 A0A024QZ33 J3QS82 ENST00000589608.1 K7ERM9 ENST00000394826.8 Q9H0G5 ENST00000584423.5 ENST00000584154.5 ENST00000475652.5 ENST00000247026.10 H7BYM1 K7EMD8 ENST00000580103.6 J3QRI6 ENST00000584317.5 ENST00000588614.1 K7EK40 ENST00000612959.4 J3QLV5 |